Greg Gocal

Greg Gocal

Founder at CALYXT, INC.

Net worth: 199 440 $ as of 2024-04-29

55 year
Health Technology
Consumer Services
Commercial Services

Network origin in Greg Gocal first degree

EntityEntity typeIndustry
Holding Company Biotechnology 16
11
Subsidiary Biotechnology 11
10
Subsidiary Biotechnology 10
Public Company Information Technology Services 8

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Greg Gocal via their personal network

CompanySectorRelated peopleMain position
CARDINAL HEALTH, INC. Medical Distributors

Jonathan Wygant

Jim Hinrichs

Corporate Officer/Principal

Director of Finance/CFO

ALERE INC Medical Specialties

Jonathan Wygant

Jim Hinrichs

Director of Finance/CFO

Director of Finance/CFO

INTERPACE BIOSCIENCES, INC. Medical Specialties

Harry Glorikian

Corporate Officer/Principal

Investment Managers

Rory Riggs

Mark Finn

Corporate Officer/Principal

Corporate Officer/Principal

CAREFUSION CORPORATION Medical Distributors

Jonathan Wygant

Jim Hinrichs

Comptroller/Controller/Auditor

Director of Finance/CFO

College/University

Jean Lehmann

Masters Business Admin

Major Banks

Mark Finn

Mark Finn

Corporate Officer/Principal

Chief Investment Officer

Boston University College/University

Harry Glorikian

Masters Business Admin

Internet Software/Services

Chang Keng Lo

Director/Board Member

FIBROGEN, INC. Pharmaceuticals: Major

Rory Riggs

Stephen Evans-Freke

Founder

Founder

Yale University College/University

Eugene Linden

Keith Walker

Undergraduate Degree

Doctorate Degree

San Francisco State University College/University

Harry Glorikian

Undergraduate Degree

Simon Fraser University College/University

Chang Keng Lo

Mark Lu

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Keith Walker

Peter Beetham

David A. Voss

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Harry Glorikian

Sales & Marketing

STAGEZERO LIFE SCIENCES LTD. Medical Specialties

Rory Riggs

Harry Glorikian

Founder

Director/Board Member

Other Consumer Services

Rory Riggs

Mark Finn

Chief Executive Officer

Director/Board Member

Investment Managers

Jean Lehmann

Corporate Officer/Principal

Investment Managers

Stephen Evans-Freke

Mark Finn

Founder

Consultant / Advisor

Food Retail

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

Kunshan Rotam Reddy Pharmaceutical Co., Ltd.

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

ROTAM GLOBAL AGROSCIENCES LIMITED Chemicals: Agricultural

Chang Keng Lo

Mark Lu

Founder

Founder

Chemicals: Agricultural

Chang Keng Lo

Director/Board Member

Rotam Investments Ltd.

Chang Keng Lo

Director/Board Member

Chemicals: Agricultural

Chang Keng Lo

Director/Board Member

Rotam Chemia Technology (HK) Ltd.

Chang Keng Lo

Director/Board Member

Triumph Year International Ltd.

Chang Keng Lo

Director/Board Member

Rotam Veterinary Co., Ltd.

Chang Keng Lo

Director/Board Member

Double Glory Holdings Ltd.

Chang Keng Lo

Director/Board Member

Witgang Far East Ltd.

Chang Keng Lo

Director/Board Member

Chemicals: Agricultural

Chang Keng Lo

Director/Board Member

Rotam India Ltd.

Chang Keng Lo

Director/Board Member

Wholesale Distributors

Chang Keng Lo

Director/Board Member

New Skyland International Ltd.

Chang Keng Lo

Director/Board Member

Crop Solutions Ltd.

Chang Keng Lo

Director/Board Member

Financial Conglomerates

Chang Keng Lo

Director/Board Member

Financial Conglomerates

Chang Keng Lo

Director/Board Member

Financial Conglomerates

Chang Keng Lo

Director/Board Member

Number Success Ltd.

Chang Keng Lo

Director/Board Member

Miscellaneous Commercial Services

Harry Glorikian

Consultant / Advisor

Containers/Packaging

Chang Keng Lo

Mark Lu

Chairman

Chairman

BIOCARTIS GROUP NV Medical Specialties

Harry Glorikian

Director/Board Member

Medical Specialties

Harry Glorikian

Founder

X-Cell Laboratories

Harry Glorikian

Founder

Investment Managers

Rory Riggs

Harry Glorikian

Mark Finn

Founder

Private Equity Investor

Private Equity Investor

Miscellaneous Commercial Services

Gerhard Prante

Portfolio Manager-Fixed Income

Pharmaceuticals: Major

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

Chong Dah Pharmaceutical Co., Ltd.

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

Statistics

International

United States 22
Hong Kong 8
Taiwan 7
Canada 4
China 4

Sectoral

Health Technology 10
Finance 10
Consumer Services 7
Process Industries 6
Distribution Services 4

Operational

Director/Board Member 164
Corporate Officer/Principal 56
Chairman 34
Founder 34
President 22
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW